ロード中...
Clinical endpoints for developing pharmaceuticals to manage patients with sporadic or genetic risk of colorectal cancer
To reduce the morbidity and mortality from colorectal cancer, current clinical practice focuses on screening for early detection and polypectomy as a form of secondary prevention, complemented with surgical interventions when appropriate. No pharmaceutical agent is currently approved for use in clin...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3587976/ https://ncbi.nlm.nih.gov/pubmed/22928902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/egh.12.23 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|